These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 20397954

  • 1. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned.
    Howard AA, El-Sadr WM.
    Clin Infect Dis; 2010 May 15; 50 Suppl 3():S238-44. PubMed ID: 20397954
    [Abstract] [Full Text] [Related]

  • 2. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG.
    Ann Afr Med; 2009 May 15; 8(3):147-55. PubMed ID: 19884690
    [Abstract] [Full Text] [Related]

  • 3. Prevention of tuberculosis in people living with HIV.
    Granich R, Akolo C, Gunneberg C, Getahun H, Williams P, Williams B.
    Clin Infect Dis; 2010 May 15; 50 Suppl 3():S215-22. PubMed ID: 20397951
    [Abstract] [Full Text] [Related]

  • 4. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection.
    Coggin WL, Ryan CA, Holmes CB.
    Clin Infect Dis; 2010 May 15; 50 Suppl 3():S255-9. PubMed ID: 20397956
    [Abstract] [Full Text] [Related]

  • 5. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
    Suthar AB, Klinkenberg E, Ramsay A, Garg N, Bennett R, Towle M, Sitienei J, Smyth C, Daniels C, Baggaley R, Gunneberg C, Williams B, Getahun H, van Gorkom J, Granich RM.
    Int J Tuberc Lung Dis; 2012 Apr 15; 16(4):430-6. PubMed ID: 22640510
    [Abstract] [Full Text] [Related]

  • 6. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes--the case of Malawi.
    Libamba E, Makombe S, Harries AD, Chimzizi R, Salaniponi FM, Schouten EJ, Mpazanje R.
    Int J Tuberc Lung Dis; 2005 Oct 15; 9(10):1062-71. PubMed ID: 16229216
    [Abstract] [Full Text] [Related]

  • 7. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D, Harries A, Getahun H.
    Trop Med Int Health; 2005 Aug 15; 10(8):734-42. PubMed ID: 16045459
    [Abstract] [Full Text] [Related]

  • 8. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD, Hargreaves NJ, Chimzizi R, Salaniponi FM.
    Bull World Health Organ; 2002 Aug 15; 80(6):464-9. PubMed ID: 12132003
    [Abstract] [Full Text] [Related]

  • 9. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies.
    Friedland G, Harries A, Coetzee D.
    J Infect Dis; 2007 Aug 15; 196 Suppl 1():S114-23. PubMed ID: 17624820
    [Abstract] [Full Text] [Related]

  • 10. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.
    Godfrey-Faussett P, Maher D, Mukadi YD, Nunn P, Perriëns J, Raviglione M.
    Bull World Health Organ; 2002 Aug 15; 80(12):939-45. PubMed ID: 12571721
    [Abstract] [Full Text] [Related]

  • 11. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD, Maher D, Nunn P.
    Bull World Health Organ; 1997 Aug 15; 75(5):477-89. PubMed ID: 9447782
    [Abstract] [Full Text] [Related]

  • 12. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F.
    East Afr Med J; 1998 Sep 15; 75(9):520-7. PubMed ID: 10493054
    [Abstract] [Full Text] [Related]

  • 13. Low-income countries: where are we going with TB-HIV in 2009?
    Mwinga A.
    Int J Tuberc Lung Dis; 2009 Jul 15; 13(7):797-8. PubMed ID: 19555525
    [No Abstract] [Full Text] [Related]

  • 14. Integrating tuberculosis and HIV care in the primary care setting in South Africa.
    Coetzee D, Hilderbrand K, Goemaere E, Matthys F, Boelaert M.
    Trop Med Int Health; 2004 Jun 15; 9(6):A11-5. PubMed ID: 15189469
    [Abstract] [Full Text] [Related]

  • 15. Contemporary treatment of tuberculosis in HIV prevalent countries in sub-Saharan Africa.
    Nuwaha F.
    East Afr Med J; 1998 Jun 15; 75(6):358-63. PubMed ID: 9803621
    [Abstract] [Full Text] [Related]

  • 16. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM.
    Am J Trop Med Hyg; 1996 Jul 15; 55(1):1-11. PubMed ID: 8702012
    [Abstract] [Full Text] [Related]

  • 17. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
    De Cock KM, Chaisson RE.
    Int J Tuberc Lung Dis; 1999 Jun 15; 3(6):457-65. PubMed ID: 10383056
    [Abstract] [Full Text] [Related]

  • 18. Trials of anti-tuberculosis treatment in areas of high human immunodeficiency virus prevalence in sub-Saharan Africa.
    Harries AD, Hargreaves NJ, Kumwenda J, Kwanjana JH, Salaniponi FM.
    Int J Tuberc Lung Dis; 2000 Nov 15; 4(11):998-1001. PubMed ID: 11092710
    [Abstract] [Full Text] [Related]

  • 19. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.
    Reid SE, Reid CA, Vermund SH.
    Int J STD AIDS; 2004 Nov 15; 15(11):713-6. PubMed ID: 15537453
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
    Burnett RJ, François G, Kew MC, Leroux-Roels G, Meheus A, Hoosen AA, Mphahlele MJ.
    Liver Int; 2005 Apr 15; 25(2):201-13. PubMed ID: 15780040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.